HSTC — HST Global, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 797564 ·
Last close
$0.65
Market Cap
$91.93M
52W High
$0.70
52W Low
$0.65
ADV30
36
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2024 | 0 | — | -13,400 | -13,792 | 1,281,070 | 10,406 | 42,076 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,549
Investing CF
—
Financing CF
$23,800
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.00
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-6,079,160
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-13,400
Pretax Income TTM
$-13,792
Interest Exp TTM
$392
Analysts
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2023 | 0 | -140,907 | -146,210 | 1,526 | 593,593 | — | -20,906 |
| Dec 2022 | 0 | -141,035 | -145,074 | 190 | 446,047 | — | -21,035 |
| Dec 2021 | 0 | -145,718 | -148,360 | 225 | 301,008 | — | -29,836 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics, Inc. | $91.70M | $1.52 | — |
| ZYBT | Zhengye Biotechnology Holding Ltd | $92.41M | $1.95 | — |
| ACRV | Acrivon Therapeutics, Inc. | $94.28M | $2.20 | — |
| RLYB | Rallybio Corp | $89.22M | $16.80 | — |
| BGM | BGM Group Ltd. | $95.31M | $0.25 | — |
Recent Insider Activity
No insider activity indexed for this ticker.